Journal of Thrombosis and Haemostasis
Издатель: Elsevier · ISSN 1538-7836 · 86 статей
- The Role of Platelet Aggregation and Activation as Biomarkers for Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage
- Not immature, but perfect for age: the hemostatic system of infants and children as a physiological masterclass
- Type 2M von Willebrand disease mutations impair platelet adhesion through distinct effects involving enhanced A1/A2 interactions
- Antiplatelet glycoprotein complex-dependent autoantibodies impair platelet function in chronic immune thrombocytopenia
- SLFN14: An Elusive Regulator of Megakaryocytes and Platelets in Inherited Thrombocytopenia
- Combination of Thrombopoietin Receptor Agonists and Rituximab in Relapsed/Refractory Immune Thrombocytopenia: A Multicenter Real-World Study
- JTH in Clinic: Venous Thromboembolism (VTE) Prophylaxis of Pediatric Patients at Risk of VTE
- The Quick and Owren prothrombin time assays: characteristics and performance in clinical routine.
- Emicizumab Prophylaxis in People with Haemophilia A: Summary of Over 13 Years of Safety Data on Thromboembolic Events and Thrombotic Microangiopathy
- Enhanced Plasmin Generation Due to PAI-1 Deficiency Impairs Regulated Vascular Endothelial Cell Motility
- Staphylococcal coagulases amplify fibrinogen-dependent NETosis by S. aureus in human neutrophils and exacerbate early thromboinflammation in mice
- From Hartert’s Thrombelastograph to Pathway-Specific Viscoelastic Testing: A Historical Sketch
- Issue Information
- Promoting diversity, equity, and inclusion in ISTH committee structures: how well are we doing?
- Pharmacology of anticoagulants: from heparin to novel target-specific agents
- Preserving expertise in vitamin K antagonists in the era of direct oral anticoagulants: avoiding therapeutic segregation
- Pulmonary embolism in immune thrombocytopenia: insights from a contemporary cohort
- Going with the flow: a new current in viral infection–induced thrombosis
- A matter of supply and demand: reconsidering persistent chemotherapy-induced thrombocytopenia
- It is time to accept the painful truth: low-molecular-weight heparin does not improve outcomes in women with pregnancy complications
- The body fights back—inflammation in acute pulmonary embolism
- Platelet sialylation as a window into GNE deficiency
- How endogenous factor IX antigen and crossreacting material positive status shape extended half-life factor IX pharmacokinetics
- Bypassing bleeding disorder of unknown cause?
- Use of factor concentrates for the management of perioperative bleeding: guidance from the ISTH SSC Subcommittee on Perioperative and Critical Care Thrombosis and Hemostasis
- Factor IX gene variants may influence the pharmacokinetic profile of patients with hemophilia B treated with Factor IX-fusion protein or N9-GP extended half-life Factor IX concentrates
- The tissue factor-TFPI pathway as a therapeutic target in bleeding disorders of unknown cause
- Mathematical modeling of flow-mediated thrombin generation after treatment of postoperative bleeding in cardiac surgery with cardiopulmonary bypass
- Pseudonaja textilis venom factor Va circumvents natural regulatory mechanisms via a unique A2 domain region
- An inducible zebrafish model of thrombocytopenia enables in vivo drug screening and reveals fibroblast growth factor signaling as a key regulator of platelet regeneration